All Biologics Content

Bringing you the latest research in Proteins and Antibodies, Peptides, and Oligonucleotides through a range of Speaker Interviews, Industry Insights, and Expert Opinions.
Written Q&A
Steinar Madsen, Medical Director, Norwegian Medicines Agency
24 April 2019
Biosimilars & Biobetters
Written Q&A
Uwe Gudat, Head Of Safety, Merck Serono
24 April 2019
Biosimilars & Biobetters
Insight Article
Dr. Philip Webber, Patent Attorney, Dehns Patent and Trade Mark Attorneys
16 April 2018
Biosimilars & Biobetters
Video Content
Video Q&A
Principal, Pharmaceutical Law Group PC, Director, Regulatory Affairs, PharmaLex UK
16 April 2018
Biosimilars & Biobetters
Insight Article
Gregory J. Glover, Attorney at Law, Pharmaceutical Law Group PC
16 April 2018
Biosimilars & Biobetters
Written Q&A
Rakesh Dixit, Vice President, R&D, Medimmune
20 April 2015
Biosimilars & Biobetters
Written Q&A
Mershid Alai-Safar, Senior Director, Regulatory Affairs, Baxter
20 April 2015
Biosimilars & Biobetters

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Biologics

Submit your details to receive the monthly newsletter & to be kept up to date about relevant events, monthly discussion groups and portal membership offers. You may opt-out at any time. Please check our Privacy Policy to see how Oxford Global protects and manages your data.